Immunotherapy advances for glioblastoma

Survival for patients with glioblastoma, the most common high-grade primary CNS tumor, remains poor despite multiple therapeutic interventions including intensifying cytotoxic therapy, targeting dysregulated cell signaling pathways, and blocking angiogenesis. Exciting, durable clinical benefits have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Reardon, David A., Freeman, Gordon, Wu, Catherine, Chiocca, E. Antonio, Wucherpfennig, Kai W., Wen, Patrick Y., Fritsch, Edward F., Curry, William T., Sampson, John H., Dranoff, Glenn
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Reviews
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201077/
https://ncbi.nlm.nih.gov/pubmed/25190673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou212
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados